Lemmer Peter, Sowa Jan-Peter, Bulut Yesim, Strnad Pavel, Canbay Ali
Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Department of Medicine, Universitätsklinikum Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.
Liver Int. 2025 Mar;45(3):e15739. doi: 10.1111/liv.15739. Epub 2023 Sep 26.
This review compiles the mechanisms of acute liver failure (ALF) as well as the current and potential therapeutic approaches, including aetiology-specific treatment, and the issues encountered with such approaches. On a cellular level, ALF is characterized by massive hepatocyte death due to different types of cellular demise. Compensatory hyperplasia and functional recovery are possible when the regenerative capacity is sufficient to sustain hepatic function. ALF has a high mortality of about 30% and can lead to death in a very short time despite maximum therapeutic intervention. Besides aetiology-specific therapy and intensive care, the therapeutic option of emergency liver transplantation has significantly improved the prognosis of patients with ALF. However, due to limiting factors such as organ shortage, many patients die on the waiting list. In addition to graft assessment, machine perfusion may have the potential to recondition marginal organs and thus expand the organ donor pool.
本综述汇总了急性肝衰竭(ALF)的发病机制以及当前和潜在的治疗方法,包括针对病因的治疗以及这些方法所面临的问题。在细胞水平上,ALF的特征是由于不同类型的细胞死亡导致大量肝细胞死亡。当再生能力足以维持肝功能时,代偿性增生和功能恢复是可能的。ALF的死亡率很高,约为30%,尽管进行了最大程度的治疗干预,仍可能在很短的时间内导致死亡。除了针对病因的治疗和重症监护外,紧急肝移植的治疗选择显著改善了ALF患者的预后。然而,由于器官短缺等限制因素,许多患者在等待名单上死亡。除了移植物评估外,机器灌注可能有潜力修复边缘器官,从而扩大器官供体库。